Growth Metrics

Astria Therapeutics (ATXS) Times Interest Earned: 2017-2018

Historic Times Interest Earned for Astria Therapeutics (ATXS) over the last 2 years, with Sep 2018 value amounting to -$600.80.

  • Astria Therapeutics' Times Interest Earned fell 807.42% to -$600.80 in Q3 2018 from the same period last year, while for Sep 2018 it was -$142.43, marking a year-over-year change of. This contributed to the annual value of -$263.71 for FY2018, which is 349.67% down from last year.
  • According to the latest figures from Q3 2018, Astria Therapeutics' Times Interest Earned is -$600.80, which was down 198.77% from -$201.09 recorded in Q2 2018.
  • Astria Therapeutics' 5-year Times Interest Earned high stood at -$52.09 for Q1 2017, and its period low was -$600.80 during Q3 2018.
  • Over the past 2 years, Astria Therapeutics' median Times Interest Earned value was -$67.86 (recorded in 2017), while the average stood at -$168.08.
  • Data for Astria Therapeutics' Times Interest Earned shows a maximum YoY plummeted of 807.42% (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Astria Therapeutics' Times Interest Earned stood at -$67.86 in 2017, then tumbled by 807.42% to -$600.80 in 2018.
  • Its last three reported values are -$600.80 in Q3 2018, -$201.09 for Q2 2018, and -$134.02 during Q1 2018.